Isolation of an immunosuppressive metabolite of FK506 generated by human microsome preparations
β Scribed by Uwe Christians; Heinfried H. Radeke; Reinhard Kownatzki; H.M. Schiebel; Renate Schottmann; Karl-Fr. Sewing
- Book ID
- 103039198
- Publisher
- Elsevier Science
- Year
- 1991
- Tongue
- English
- Weight
- 378 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0009-9120
No coin nor oath required. For personal study only.
β¦ Synopsis
Metabolism of FK506, a 23 member macrolide under clinical investigation as immunosuppressant after transplantation, was studied using human liver microsomes. Two fractions isolated by semipreparative HPLC were identified by negative fast atom bombardment mass spectrometry as FK506 metabolites with mass peaks at m/z = 790 indicating demethylation of the mother compound. The immunosuppressive activity of one metabolite was evaluated in a ConA-stimulated peripheral rat lymphocyte assay. FK506 had an ICso of 0.186 nmol/L and the metabolite tested of 1.89 nmol/L.
π SIMILAR VOLUMES
FK506 is currently under investigation as immunosuppressant after organ transplantation and in immune diseases. The structure of a demethylated metabolite 1 of FK506 isolated after in oitro metabolism by human-liver microsomes was established using two-dimensional homo-and heteronuclear NMR experime
The isolation from human liver microsomes and identiΓcation by electrospray mass spectrometry and tandem mass spectrometry of a new metabolite of IMM-125 resulting from the biotransformation of the amino acid 1 vinylic methyl group to a carboxylic acid, called the IMM-125-COOH metabolite, is describ
It was demonstrated that rapamycin is metabolized in vitro by pig liver microsomes under the inΓuence of the cytochrome P450-dependent mixed function oxygenase system to a rapamycin tris-epoxide metabolite, as demonstrated by electrospray tandem mass spectrometry . The in vitro immunosuppressive act